Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

Sponsor
Duramed Research (Industry)
Overall Status
Completed
CT.gov ID
NCT00362479
Collaborator
(none)
1,347
85
1
11
15.8
1.4

Study Details

Study Description

Brief Summary

This is an open-label, single treatment study. All subjects will receive 6 months of oral contraceptive therapy with DR-1021. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary.

Condition or Disease Intervention/Treatment Phase
Phase 3

Detailed Description

The overall study duration for each patient will be approximately 8 months, which includes a screening period of approximately 4 weeks; a treatment period of approximately six months (six,28-day cycles); and a follow-up visit approximately 4 weeks after completion of study drug.

Study Design

Study Type:
Interventional
Actual Enrollment :
1347 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
A Prospective, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of the 28-Day Oral Contraceptive DR-1021
Study Start Date :
Aug 1, 2006
Actual Primary Completion Date :
Jul 1, 2007
Actual Study Completion Date :
Jul 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Drug: DR-1021
1 tablet daily

Outcome Measures

Primary Outcome Measures

  1. Evaluation of pregnancy rates [Duration of study]

Secondary Outcome Measures

  1. Adverse events reported by patients and investigators [Duration of study]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Premenopausal

  • Not pregnant or breastfeeding

  • Sexually active at risk of pregnancy

Exclusion Criteria:
  • Any contraindication to the use of oral contraceptives

  • Pregnancy within the last 3 months

  • Smoking > 10 cigarettes per day

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duramed Investigational Site Huntsville Alabama United States 35801
2 Duramed Investigational Site Mobile Alabama United States 36608
3 Duramed Investigational Site Phoenix Arizona United States 85015
4 Duramed Investigational Site Phoenix Arizona United States 85031
5 Duramed Investigational Site Carmichael California United States 95608
6 Duramed Investigational Site Irvine California United States 92618
7 Duramed Investigational Site San Diego California United States 92108
8 Duramed Investigational Site San Diego California United States 92123
9 Duramed Investigational Site San Ramon California United States 94583
10 Duramed Investigational Site Colorado Springs Colorado United States 80909
11 Duramed Investigational Site Lakewood Colorado United States 80228
12 Duramed Investigational Site Wilmington Delaware United States 19805
13 Duramed Investigational Site Washington District of Columbia United States 20006
14 Duramed Investigational Site Aventura Florida United States 33180
15 Duramed Investigational Site Boynton Beach Florida United States 33437
16 Duramed Investigational Site Brooksville Florida United States 33613
17 Duramed Investigational Site Clearwater Florida United States 33761
18 Duramed Investigational Site Coral Gables Florida United States 33134
19 Duramed Investigational Site Fort Meyers Florida United States 33918
20 Duramed Investigational Site Leesburg Florida United States 34748
21 Duramed Investigational Site Longwood Florida United States 32779
22 Duramed Investigational Site Miami Florida United States 33173
23 Duramed Investigational Site Pinellas Park Florida United States 33781
24 Duramed Investigational Site Sarasota Florida United States 34239
25 Duramed Investigational Site St. Petersburg Florida United States 33702
26 Duramed Investigational Site St. Petersburg Florida United States 33709
27 Duramed Investigational Site Tampa Florida United States 33613
28 Duramed Investigational Site West Palm Beach Florida United States 33409
29 Duramed Investigational Site Atlanta Georgia United States 30328
30 Duramed Investigational Site Atlanta Georgia United States 30342
31 Duramed Investigational Site Decatur Georgia United States 30034
32 Duramed Investigational Site Roswell Georgia United States 30075
33 Duramed Investigational Site Boise Idaho United States 83704
34 Duramed Investigational Site Chicago Illinois United States 60611
35 Duramed Investigational Site Chicago Illinois United States 60612
36 Duramed Investigational Site Peoria Illinois United States 61602
37 Duramed Investigational Site Shawnee Mission Kansas United States 66216
38 Duramed Investigational Site Topeka Kansas United States 66614
39 Duramed Investigational Site Lexington Kentucky United States 40509
40 Duramed Investigational Site Louisville Kentucky United States 40291
41 Duramed Investigational Site Mt Sterling Kentucky United States 40353
42 Duramed Investigational Site Kansas City Missouri United States 64108
43 Duramed Investigational Site Lincoln Nebraska United States 68510
44 Duramed Investigational Site Las Vegas Nevada United States 89146
45 Duramed Investigational Site Moorestown New Jersey United States 08057
46 Duramed Investigational Site New Brunswick New Jersey United States 08901
47 Duramed Investigational Site Albuquerque New Mexico United States 87102
48 Duramed Investigational Site Johnson City New York United States 13790
49 Duramed Investigational Site Rochester New York United States 14609
50 Duramed Investigational Site Charlotte North Carolina United States 28211
51 Duramed Investigational Site Raleigh North Carolina United States 27612
52 Duramed Investigational Site Wilmington North Carolina United States 28412
53 Duramed Investigational Site Winston-Salem North Carolina United States 27103
54 Duramed Investigational Site Columbus Ohio United States 43210
55 Duramed Investigational Site Columbus Ohio United States 43213
56 Duramed Investigational Site Oklahoma City Oklahoma United States 73112
57 Duramed Investigational Site Medford Oregon United States 97504
58 Duramed Investigational Site Philadelphia Pennsylvania United States 19114
59 Duramed Investigational Site Reading Pennsylvania United States 19606
60 Duramed Investigational Site Cranston Rhode Island United States 02920
61 Duramed Investigational Site Greer South Carolina United States 29651
62 Duramed Investigational Site Mt Pleasant South Carolina United States 29464
63 Duramed Investigational Site Bristol Tennessee United States 37620
64 Duramed Investigational Site Chattanooga Tennessee United States 37404
65 Duramed Investigational Site Clarksville Tennessee United States 37043
66 Duramed Investigational Site Germantown Tennessee United States 38138
67 Duramed Investigational Site Knoxville Tennessee United States 37920
68 Duramed Investigational Site Nashville Tennessee United States 37203
69 Duramed Investigational Site Austin Texas United States 78759
70 Duramed Investigational Site Dallas Texas United States 75234
71 Duramed Investigational Site Houston Texas United States 77030
72 Duramed Investigational Site San Antonio Texas United States 78229
73 Duramed Investigational Site Waco Texas United States 76712
74 Duramed Investigational Site Magna Utah United States 84044
75 Duramed Investigational Site Pleasant Grove Utah United States 84062
76 Duramed Investigational Site Salt Lake City Utah United States 84124
77 Duramed Investigational Site Sandy Utah United States 84070
78 Duramed Investigational Site Arlington Virginia United States 22203
79 Duramed Investigational Site Newport News Virginia United States 23602
80 Duramed Investigational Site Norfolk Virginia United States 23507
81 Duramed Investigational Site Richmond Virginia United States 23233
82 Duramed Investigational Site Lakewood Washington United States 98499
83 Duramed Investigational Site Seattle Washington United States 98105
84 Duramed Investigational Site Spokane Washington United States 99207
85 Duramed Investigational Site Tacoma Washington United States 98405

Sponsors and Collaborators

  • Duramed Research

Investigators

  • Principal Investigator: Duramed Medical Monitor, Duramed Research

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00362479
Other Study ID Numbers:
  • DR-DSG-301
First Posted:
Aug 10, 2006
Last Update Posted:
Aug 21, 2013
Last Verified:
Aug 1, 2013
Keywords provided by , ,

Study Results

No Results Posted as of Aug 21, 2013